Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0586 USD | -76.56% | -.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Cares and Supplements Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -95.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -95.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 46 | 19-08-19 |
Li Yang
BRD | Director/Board Member | 55 | 19-08-19 |
Hua Xie
BRD | Director/Board Member | 54 | 19-08-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Shuang Liu
CEO | Chief Executive Officer | 46 | 19-08-19 |
Hua Xie
BRD | Director/Board Member | 54 | 19-08-19 |
Li Yang
BRD | Director/Board Member | 55 | 19-08-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,000,000 | 43,000,000 ( 43.43 %) | 0 | 43.43 % |
Company contact information
Goldenwell Biotech, Inc.
581 Boston Mills Road Suite 300
44236, Hudson
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.8M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GWLL Stock
- Company Goldenwell Biotech, Inc.